Market Outlook
The global Pharmaceutical Excipients market size was valued at USD 99110 million in 2022 and is forecast to a readjusted size of USD 140400 million by 2029 with a CAGR of 5.1% during review period.
Pharmaceutical excipients are substances that are included in a pharmaceutical dosage form not for their direct therapeutic action, but to aid the manufacturing process, to protect, support or enhance stability, or for bioavailability or patient acceptability.
Global top ten manufacturers hold a share about 4%. North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific, have a share over 57 percent. In terms of Production, Cellulose and Derivatives is the largest segment, with a share over 51%. And in terms of Application, the largest application is Solid Preparation Excipients, followed by Semi-Solid Preparation Excipients, Liquid Preparation Excipients, etc.
Report includes an overview of the development of the Pharmaceutical Excipients industry chain, the market status of Oral Formulations (Triglycerides, Mannitol), Topical Formulations (Triglycerides, Mannitol), and key enterprises in developed and developing market, and analyzed the cutting-edge technology, patent, hot applications and market trends of Pharmaceutical Excipients.
Regionally, the report analyzes the Pharmaceutical Excipients markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pharmaceutical Excipients market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pharmaceutical Excipients market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pharmaceutical Excipients industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Tons), revenue generated, and market share of different by Type (e.g., Triglycerides, Mannitol).
Industry Analysis: Report analyze the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pharmaceutical Excipients market.
Regional Analysis: The report involves examining the Pharmaceutical Excipients market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behavior to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pharmaceutical Excipients market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pharmaceutical Excipients:
Company Analysis: Report covers individual Pharmaceutical Excipients manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behavior, preferences, and attitudes towards Pharmaceutical Excipients This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oral Formulations, Topical Formulations).
Technology Analysis: Report covers specific technologies relevant to Pharmaceutical Excipients. It assesses the current state, advancements, and potential future developments in Pharmaceutical Excipients areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pharmaceutical Excipients market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Key Market Players
DowDuPont (FMC)
JRS Pharma
BASF
Lubrizol
Ashland
Croda International
Roquette
Shin-Etsu
Evonik
Associated British Foods
Hunan ER-KANG
Anhui Sunhere
Tianjin Chase Sun
Mitsubishi
Segmentation By Type
Triglycerides
Mannitol
Sorbitol
Sucrose
Dextrose
Starch
Others
Segmentation By Application
Oral Formulations
Topical Formulations
Parenteral Formulations
Other
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Pharmaceutical Excipients Market in 2025?
The Pharmaceutical Excipients Market in 2025 will benefit from growing demand for personalized medicine, advancements in drug formulation technologies, and increasing awareness about the role of excipients in drug efficacy and safety. Additionally, regulatory advancements and rising investments in R&D will drive innovation in excipient development.
What weaknesses could hinder the Pharmaceutical Excipients Market in 2025?
One of the key weaknesses could be the high cost of specialized excipients, limiting their widespread adoption in certain regions. Regulatory hurdles and the complexity of developing new excipients for specific formulations could also slow down market growth. Moreover, the lack of awareness in emerging markets about the importance of excipients could pose challenges.
What opportunities exist in the Pharmaceutical Excipients Market in 2025?
Opportunities include increasing demand for biologics and vaccines, which require advanced excipients to enhance stability and delivery. The rising trend of green and sustainable excipients could open new avenues for market expansion. Additionally, the growth of over-the-counter (OTC) and generic drug markets presents potential for excipient innovations tailored for cost-effective production.
What threats could affect the Pharmaceutical Excipients Market in 2025?
The market could face threats from stringent regulations around excipient safety and quality, which could slow down the development process. The rise of counterfeit drugs and excipients may also pose a risk to both patient safety and market growth. Finally, competition from alternative delivery methods or technologies, such as nanotechnology, could challenge traditional excipient demand.
Market PESTEL Analysis
What are the political factors affecting the Pharmaceutical Excipients Market in 2025?
Political stability and government regulations will play a significant role in shaping the market. Policies aimed at improving drug safety, quality control, and manufacturing standards will influence the adoption of excipients. Governments in key markets may introduce new laws to promote sustainable and ethical excipient sourcing, while trade policies and tariffs could impact global supply chains.
How do economic factors impact the Pharmaceutical Excipients Market in 2025?
Economic growth in emerging markets will drive demand for pharmaceutical products, consequently boosting the excipients market. However, cost pressures from healthcare systems, especially in developed countries, could lead to a preference for cheaper excipients or generic alternatives. Economic instability could also disrupt manufacturing and lead to fluctuations in excipient pricing.
What are the social factors influencing the Pharmaceutical Excipients Market in 2025?
Increasing healthcare awareness and the growing trend of personalized medicine will fuel the need for more sophisticated excipients that can improve drug delivery and efficacy. Additionally, an aging population will drive demand for medicines that require specialized excipients for better stability and absorption. Social concerns about sustainability could also push the market toward eco-friendly and biocompatible excipient alternatives.
How do technological factors affect the Pharmaceutical Excipients Market in 2025?
Technological advancements in drug formulation, such as nanotechnology and 3D printing, will create new opportunities for excipient innovation. The growing trend of biologics and biosimilars will require excipients designed for complex formulations. Continuous research into novel excipients for targeted delivery will also be pivotal in driving market growth, as will digital technologies enhancing manufacturing processes.
What environmental factors will impact the Pharmaceutical Excipients Market in 2025?
There is a rising global focus on sustainability and reducing environmental footprints, prompting manufacturers to adopt greener excipients derived from renewable sources. Regulations around waste management and environmental impact of pharmaceutical manufacturing processes may drive innovation in eco-friendly excipient production. Climate change could also affect the availability of raw materials for excipients, influencing supply chains.
What legal factors will shape the Pharmaceutical Excipients Market in 2025?
Stringent regulatory frameworks governing the safety and quality of excipients will continue to impact the market. The introduction of new compliance standards for excipient manufacturing processes, particularly in emerging markets, could drive up production costs. Legal challenges related to intellectual property and patents for new excipients may also affect market dynamics and competition.
Market SIPOC Analysis
Who are the suppliers in the Pharmaceutical Excipients Market in 2025?
Suppliers include raw material providers, such as agricultural and chemical companies, that produce excipient ingredients like starches, sugars, and polymers. Specialized manufacturers of excipients, along with regulatory bodies that ensure compliance with safety standards, will also play a key role in the supply chain. Additionally, technology providers supporting excipient development and formulation will be crucial.
Who are the inputs required in the Pharmaceutical Excipients Market in 2025?
The inputs required include raw materials such as plant-based and synthetic compounds for excipient formulation, advanced technologies for drug delivery systems, and scientific knowledge for excipient innovation. Regulatory standards, quality control processes, and industry research on biocompatibility and stability are also critical inputs. Furthermore, sustainable sourcing practices will increasingly be important.
What are the processes involved in the Pharmaceutical Excipients Market in 2025?
The processes in the pharmaceutical excipients market include the development, testing, and manufacturing of excipients that meet specific pharmaceutical needs. This includes selecting suitable excipients for drug formulations, conducting stability and compatibility testing, ensuring compliance with regulations, and maintaining stringent quality control during manufacturing. Additionally, companies are likely to focus on improving sustainability in the production of excipients.
Who are the customers of the Pharmaceutical Excipients Market in 2025?
Customers in the excipients market will include pharmaceutical companies, biotech firms, and contract manufacturers who rely on excipients for drug formulation. Additionally, contract research organizations (CROs) and regulatory bodies that oversee drug safety and compliance will be significant stakeholders. The healthcare sector, including hospitals and clinics, indirectly benefits as they use drugs formulated with excipients.
What are the outputs of the Pharmaceutical Excipients Market in 2025?
The outputs of the market will be a wide range of excipients designed for specific drug formulations, including those for tablets, injectables, biologics, and oral solutions. These excipients will be optimized for drug stability, bioavailability, and patient safety. The market will also produce research and development innovations, including sustainable excipients and improved technologies for drug delivery systems.
Market Porter's Five Forces
How intense is the threat of new entrants in the Pharmaceutical Excipients Market in 2025?
The threat of new entrants is moderate. While the barriers to entry in the excipients market may seem low in terms of basic manufacturing, the need for regulatory compliance, high R&D investment, and the complexity of developing safe and effective excipients create significant hurdles for new players. Established players with strong distribution networks and technical expertise will continue to dominate.
How strong is the bargaining power of suppliers in the Pharmaceutical Excipients Market in 2025?
The bargaining power of suppliers is moderate to high. Raw material suppliers, especially those providing specialized ingredients like polymers, plant-based excipients, or advanced biocompatible compounds, hold significant power. However, the increasing focus on sustainability and alternative sourcing may lead to more options, slightly reducing this power in the long run.
How strong is the bargaining power of buyers in the Pharmaceutical Excipients Market in 2025?
The bargaining power of buyers is moderate. Pharmaceutical companies, particularly large ones, may exert some influence over pricing due to their scale and long-term contracts. However, the need for high-quality, customized excipients for specific drug formulations means that buyers are often reliant on specialized suppliers, which limits their bargaining power.
What is the threat of substitute products in the Pharmaceutical Excipients Market in 2025?
The threat of substitutes is moderate to high. As new drug delivery technologies, such as nanotechnology and biodegradable materials, continue to advance, they may offer alternative solutions to traditional excipients. Additionally, the growing emphasis on biologics and personalized medicine could lead to the use of non-traditional excipients or completely new formulation strategies that reduce dependency on conventional excipients.
How intense is the rivalry among existing competitors in the Pharmaceutical Excipients Market in 2025?
The rivalry among existing competitors is high. The market is dominated by a few large players who are continuously innovating and looking to expand their product portfolios to meet the increasing demand for specialized excipients. With growing competition in both established and emerging markets, companies are focusing on differentiation through advanced R&D, sustainable products, and enhanced customer service, intensifying competition.
Market Upstream Analysis
What are the key upstream drivers in the Pharmaceutical Excipients Market in 2025?
Key upstream drivers include the growing demand for advanced excipients in the formulation of biologics and personalized medicines. Innovations in excipient technologies, such as the development of sustainable and plant-based alternatives, will drive upstream activity. Furthermore, increasing investment in R&D by pharmaceutical companies and the rise in global health issues like chronic diseases and aging populations will continue to fuel demand for specialized excipients.
What raw materials are critical for the Pharmaceutical Excipients Market in 2025?
Critical raw materials for the pharmaceutical excipients market include natural polymers, starches, sugars, cellulose derivatives, and synthetic materials like polyethylene glycols. Additionally, biopolymers, including chitosan and hyaluronic acid, are gaining traction due to their biocompatibility and versatility. The sourcing of these materials will be influenced by both cost and sustainability factors, with increasing emphasis on renewable sources.
What are the upstream challenges facing the Pharmaceutical Excipients Market in 2025?
Upstream challenges include fluctuating raw material costs, particularly for specialty excipients, and the environmental impact of sourcing these materials. Additionally, maintaining consistent quality and purity in excipient production remains a critical challenge. Supply chain disruptions due to geopolitical issues or natural disasters, as well as regulatory changes, could also impact the availability of essential raw materials.
How do regulatory requirements affect the upstream activities in the Pharmaceutical Excipients Market in 2025?
Regulatory requirements have a significant impact on upstream activities, as excipient manufacturers must comply with stringent standards set by health authorities like the FDA, EMA, and others. This includes meeting specific safety, quality, and environmental regulations for excipient production. Compliance with these regulations often leads to higher production costs and longer time-to-market for new excipients, making it essential for upstream players to invest in quality assurance and regulatory expertise.
What role does technology play in upstream operations in the Pharmaceutical Excipients Market in 2025?
Technology plays a crucial role in upstream operations, particularly in the development and production of advanced excipients. Innovations in automation, data analytics, and process optimization are enabling more efficient and sustainable production processes. Furthermore, advancements in material science, such as the development of excipients with improved bioavailability or targeted delivery properties, will enhance the functionality of drugs, driving demand for cutting-edge technologies in the upstream value chain.
Market Midstream Analysis
What are the key midstream activities in the Pharmaceutical Excipients Market in 2025?
Key midstream activities include the manufacturing, formulation, and testing of pharmaceutical excipients. This involves transforming raw materials into excipients that meet specific pharmaceutical requirements, such as stability, bioavailability, and compatibility. Additionally, midstream activities focus on ensuring compliance with regulatory standards, conducting stability studies, and optimizing excipient performance for various drug delivery systems.
How does the supply chain operate in the Pharmaceutical Excipients Market in 2025?
The supply chain in the pharmaceutical excipients market operates through a network of specialized manufacturers, distributors, and contract research organizations (CROs). Manufacturers source raw materials from upstream suppliers and develop excipients tailored for specific drug formulations. Distributors then handle the logistics and delivery to pharmaceutical companies and contract manufacturers, who incorporate these excipients into final drug products.
What are the key challenges in the midstream segment of the Pharmaceutical Excipients Market in 2025?
Key challenges include ensuring consistent quality and purity of excipients while meeting strict regulatory standards. There is also the complexity of managing a diverse portfolio of excipients for various drug formulations. In addition, the supply chain may face disruptions due to geopolitical factors, economic instability, or unexpected changes in demand, which could impact production timelines and delivery schedules.
What role does innovation play in the midstream segment of the Pharmaceutical Excipients Market in 2025?
Innovation plays a critical role in the midstream segment, particularly in the development of new excipients that improve drug delivery, stability, and patient outcomes. Advances in excipient technology, such as bio-based or multifunctional excipients, are crucial for the pharmaceutical industry to meet the growing demand for more targeted and effective drug formulations. The integration of new manufacturing techniques, such as continuous manufacturing or nanotechnology, also drives innovation in this segment.
How do regulations impact the midstream operations in the Pharmaceutical Excipients Market in 2025?
Regulations significantly impact midstream operations by setting the standards for excipient safety, quality, and manufacturing processes. Strict regulatory requirements, such as those from the FDA and EMA, mandate comprehensive testing, traceability, and documentation for all excipient batches. This ensures the excipients meet the required specifications for use in drug formulations but also increases the time and cost associated with manufacturing and testing processes.
Market Downstream Analysis
What are the key downstream activities in the Pharmaceutical Excipients Market in 2025?
Key downstream activities include the incorporation of excipients into final pharmaceutical formulations, ensuring product stability, and conducting extensive testing before commercial distribution. These activities also involve packaging, regulatory approval processes, and the distribution of finished drug products to pharmacies, hospitals, and clinics. Ensuring consistent supply and maintaining relationships with end-users, such as pharmaceutical companies and healthcare providers, is also vital.
How does demand for pharmaceutical products affect the downstream segment of the Pharmaceutical Excipients Market in 2025?
Demand for pharmaceutical products directly impacts the downstream segment, as excipients are critical components in drug formulations. The rising prevalence of chronic diseases, the growing focus on biologics, and the increasing use of personalized medicine will drive demand for more specialized excipients. As the demand for new and complex drug formulations increases, pharmaceutical companies will rely on innovative excipients to ensure product effectiveness, safety, and patient compliance.
What are the main challenges in the downstream segment of the Pharmaceutical Excipients Market in 2025?
Challenges in the downstream segment include ensuring the timely delivery of excipient-infused drug products to meet increasing global demand, especially in emerging markets. Additionally, maintaining the stability and quality of excipient-based formulations during transport and storage remains critical. Regulatory hurdles, especially in regions with stringent drug approval processes, and the rising cost pressures from healthcare systems, also present ongoing challenges.
What role does customer feedback play in the downstream operations of the Pharmaceutical Excipients Market in 2025?
Customer feedback is essential for the downstream segment, as it provides insights into the effectiveness and performance of excipient-based drug formulations. Pharmaceutical companies often rely on feedback from healthcare providers and patients to optimize formulations and improve product quality. Additionally, feedback can help identify emerging trends or unmet needs in drug delivery, guiding the development of new excipients to meet these demands.
How do distribution channels impact the downstream segment of the Pharmaceutical Excipients Market in 2025?
Distribution channels are vital for ensuring the efficient and widespread availability of excipient-based drug formulations. Pharmaceutical companies will depend on robust logistics networks to deliver their products globally, particularly to remote or underserved regions. Efficient distribution channels help maintain a consistent supply of essential medications, and any disruption in these channels can lead to stock shortages, affecting both pharmaceutical companies and end consumers.
Chapter 1, to describe Pharmaceutical Excipients product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pharmaceutical Excipients, with price, sales, revenue and global market share of Pharmaceutical Excipients from 2018 to 2023.
Chapter 3, the Pharmaceutical Excipients competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Excipients breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical Excipients market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pharmaceutical Excipients.
Chapter 14 and 15, to describe Pharmaceutical Excipients sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical Excipients
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pharmaceutical Excipients Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Triglycerides
1.3.3 Mannitol
1.3.4 Sorbitol
1.3.5 Sucrose
1.3.6 Dextrose
1.3.7 Starch
1.3.8 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Pharmaceutical Excipients Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Oral Formulations
1.4.3 Topical Formulations
1.4.4 Parenteral Formulations
1.4.5 Other
1.5 Global Pharmaceutical Excipients Market Size & Forecast
1.5.1 Global Pharmaceutical Excipients Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pharmaceutical Excipients Sales Quantity (2018-2029)
1.5.3 Global Pharmaceutical Excipients Average Price (2018-2029)
2 Manufacturers Profiles
2.1 DowDuPont (FMC)
2.1.1 DowDuPont (FMC) Details
2.1.2 DowDuPont (FMC) Major Business
2.1.3 DowDuPont (FMC) Pharmaceutical Excipients Product and Services
2.1.4 DowDuPont (FMC) Pharmaceutical Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 DowDuPont (FMC) Recent Developments/Updates
2.2 JRS Pharma
2.2.1 JRS Pharma Details
2.2.2 JRS Pharma Major Business
2.2.3 JRS Pharma Pharmaceutical Excipients Product and Services
2.2.4 JRS Pharma Pharmaceutical Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 JRS Pharma Recent Developments/Updates
2.3 BASF
2.3.1 BASF Details
2.3.2 BASF Major Business
2.3.3 BASF Pharmaceutical Excipients Product and Services
2.3.4 BASF Pharmaceutical Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BASF Recent Developments/Updates
2.4 Lubrizol
2.4.1 Lubrizol Details
2.4.2 Lubrizol Major Business
2.4.3 Lubrizol Pharmaceutical Excipients Product and Services
2.4.4 Lubrizol Pharmaceutical Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lubrizol Recent Developments/Updates
2.5 Ashland
2.5.1 Ashland Details
2.5.2 Ashland Major Business
2.5.3 Ashland Pharmaceutical Excipients Product and Services
2.5.4 Ashland Pharmaceutical Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Ashland Recent Developments/Updates
2.6 Croda International
2.6.1 Croda International Details
2.6.2 Croda International Major Business
2.6.3 Croda International Pharmaceutical Excipients Product and Services
2.6.4 Croda International Pharmaceutical Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Croda International Recent Developments/Updates
2.7 Roquette
2.7.1 Roquette Details
2.7.2 Roquette Major Business
2.7.3 Roquette Pharmaceutical Excipients Product and Services
2.7.4 Roquette Pharmaceutical Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Roquette Recent Developments/Updates
2.8 Shin-Etsu
2.8.1 Shin-Etsu Details
2.8.2 Shin-Etsu Major Business
2.8.3 Shin-Etsu Pharmaceutical Excipients Product and Services
2.8.4 Shin-Etsu Pharmaceutical Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Shin-Etsu Recent Developments/Updates
2.9 Evonik
2.9.1 Evonik Details
2.9.2 Evonik Major Business
2.9.3 Evonik Pharmaceutical Excipients Product and Services
2.9.4 Evonik Pharmaceutical Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Evonik Recent Developments/Updates
2.10 Associated British Foods
2.10.1 Associated British Foods Details
2.10.2 Associated British Foods Major Business
2.10.3 Associated British Foods Pharmaceutical Excipients Product and Services
2.10.4 Associated British Foods Pharmaceutical Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Associated British Foods Recent Developments/Updates
2.11 Hunan ER-KANG
2.11.1 Hunan ER-KANG Details
2.11.2 Hunan ER-KANG Major Business
2.11.3 Hunan ER-KANG Pharmaceutical Excipients Product and Services
2.11.4 Hunan ER-KANG Pharmaceutical Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Hunan ER-KANG Recent Developments/Updates
2.12 Anhui Sunhere
2.12.1 Anhui Sunhere Details
2.12.2 Anhui Sunhere Major Business
2.12.3 Anhui Sunhere Pharmaceutical Excipients Product and Services
2.12.4 Anhui Sunhere Pharmaceutical Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Anhui Sunhere Recent Developments/Updates
2.13 Tianjin Chase Sun
2.13.1 Tianjin Chase Sun Details
2.13.2 Tianjin Chase Sun Major Business
2.13.3 Tianjin Chase Sun Pharmaceutical Excipients Product and Services
2.13.4 Tianjin Chase Sun Pharmaceutical Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Tianjin Chase Sun Recent Developments/Updates
2.14 Mitsubishi
2.14.1 Mitsubishi Details
2.14.2 Mitsubishi Major Business
2.14.3 Mitsubishi Pharmaceutical Excipients Product and Services
2.14.4 Mitsubishi Pharmaceutical Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Mitsubishi Recent Developments/Updates
3 Competitive Environment: Pharmaceutical Excipients by Manufacturer
3.1 Global Pharmaceutical Excipients Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pharmaceutical Excipients Revenue by Manufacturer (2018-2023)
3.3 Global Pharmaceutical Excipients Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pharmaceutical Excipients by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pharmaceutical Excipients Manufacturer Market Share in 2022
3.4.2 Top 6 Pharmaceutical Excipients Manufacturer Market Share in 2022
3.5 Pharmaceutical Excipients Market: Overall Company Footprint Analysis
3.5.1 Pharmaceutical Excipients Market: Region Footprint
3.5.2 Pharmaceutical Excipients Market: Company Product Type Footprint
3.5.3 Pharmaceutical Excipients Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pharmaceutical Excipients Market Size by Region
4.1.1 Global Pharmaceutical Excipients Sales Quantity by Region (2018-2029)
4.1.2 Global Pharmaceutical Excipients Consumption Value by Region (2018-2029)
4.1.3 Global Pharmaceutical Excipients Average Price by Region (2018-2029)
4.2 North America Pharmaceutical Excipients Consumption Value (2018-2029)
4.3 Europe Pharmaceutical Excipients Consumption Value (2018-2029)
4.4 Asia-Pacific Pharmaceutical Excipients Consumption Value (2018-2029)
4.5 South America Pharmaceutical Excipients Consumption Value (2018-2029)
4.6 Middle East and Africa Pharmaceutical Excipients Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Pharmaceutical Excipients Sales Quantity by Type (2018-2029)
5.2 Global Pharmaceutical Excipients Consumption Value by Type (2018-2029)
5.3 Global Pharmaceutical Excipients Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Pharmaceutical Excipients Sales Quantity by Application (2018-2029)
6.2 Global Pharmaceutical Excipients Consumption Value by Application (2018-2029)
6.3 Global Pharmaceutical Excipients Average Price by Application (2018-2029)
7 North America
7.1 North America Pharmaceutical Excipients Sales Quantity by Type (2018-2029)
7.2 North America Pharmaceutical Excipients Sales Quantity by Application (2018-2029)
7.3 North America Pharmaceutical Excipients Market Size by Country
7.3.1 North America Pharmaceutical Excipients Sales Quantity by Country (2018-2029)
7.3.2 North America Pharmaceutical Excipients Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Pharmaceutical Excipients Sales Quantity by Type (2018-2029)
8.2 Europe Pharmaceutical Excipients Sales Quantity by Application (2018-2029)
8.3 Europe Pharmaceutical Excipients Market Size by Country
8.3.1 Europe Pharmaceutical Excipients Sales Quantity by Country (2018-2029)
8.3.2 Europe Pharmaceutical Excipients Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Pharmaceutical Excipients Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pharmaceutical Excipients Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pharmaceutical Excipients Market Size by Region
9.3.1 Asia-Pacific Pharmaceutical Excipients Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pharmaceutical Excipients Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Pharmaceutical Excipients Sales Quantity by Type (2018-2029)
10.2 South America Pharmaceutical Excipients Sales Quantity by Application (2018-2029)
10.3 South America Pharmaceutical Excipients Market Size by Country
10.3.1 South America Pharmaceutical Excipients Sales Quantity by Country (2018-2029)
10.3.2 South America Pharmaceutical Excipients Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Pharmaceutical Excipients Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pharmaceutical Excipients Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pharmaceutical Excipients Market Size by Country
11.3.1 Middle East & Africa Pharmaceutical Excipients Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pharmaceutical Excipients Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Pharmaceutical Excipients Market Drivers
12.2 Pharmaceutical Excipients Market Restraints
12.3 Pharmaceutical Excipients Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Pharmaceutical Excipients and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pharmaceutical Excipients
13.3 Pharmaceutical Excipients Production Process
13.4 Pharmaceutical Excipients Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pharmaceutical Excipients Typical Distributors
14.3 Pharmaceutical Excipients Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Pharmaceutical Excipients Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pharmaceutical Excipients Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. DowDuPont (FMC) Basic Information, Manufacturing Base and Competitors
Table 4. DowDuPont (FMC) Major Business
Table 5. DowDuPont (FMC) Pharmaceutical Excipients Product and Services
Table 6. DowDuPont (FMC) Pharmaceutical Excipients Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. DowDuPont (FMC) Recent Developments/Updates
Table 8. JRS Pharma Basic Information, Manufacturing Base and Competitors
Table 9. JRS Pharma Major Business
Table 10. JRS Pharma Pharmaceutical Excipients Product and Services
Table 11. JRS Pharma Pharmaceutical Excipients Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. JRS Pharma Recent Developments/Updates
Table 13. BASF Basic Information, Manufacturing Base and Competitors
Table 14. BASF Major Business
Table 15. BASF Pharmaceutical Excipients Product and Services
Table 16. BASF Pharmaceutical Excipients Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BASF Recent Developments/Updates
Table 18. Lubrizol Basic Information, Manufacturing Base and Competitors
Table 19. Lubrizol Major Business
Table 20. Lubrizol Pharmaceutical Excipients Product and Services
Table 21. Lubrizol Pharmaceutical Excipients Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Lubrizol Recent Developments/Updates
Table 23. Ashland Basic Information, Manufacturing Base and Competitors
Table 24. Ashland Major Business
Table 25. Ashland Pharmaceutical Excipients Product and Services
Table 26. Ashland Pharmaceutical Excipients Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Ashland Recent Developments/Updates
Table 28. Croda International Basic Information, Manufacturing Base and Competitors
Table 29. Croda International Major Business
Table 30. Croda International Pharmaceutical Excipients Product and Services
Table 31. Croda International Pharmaceutical Excipients Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Croda International Recent Developments/Updates
Table 33. Roquette Basic Information, Manufacturing Base and Competitors
Table 34. Roquette Major Business
Table 35. Roquette Pharmaceutical Excipients Product and Services
Table 36. Roquette Pharmaceutical Excipients Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Roquette Recent Developments/Updates
Table 38. Shin-Etsu Basic Information, Manufacturing Base and Competitors
Table 39. Shin-Etsu Major Business
Table 40. Shin-Etsu Pharmaceutical Excipients Product and Services
Table 41. Shin-Etsu Pharmaceutical Excipients Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Shin-Etsu Recent Developments/Updates
Table 43. Evonik Basic Information, Manufacturing Base and Competitors
Table 44. Evonik Major Business
Table 45. Evonik Pharmaceutical Excipients Product and Services
Table 46. Evonik Pharmaceutical Excipients Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Evonik Recent Developments/Updates
Table 48. Associated British Foods Basic Information, Manufacturing Base and Competitors
Table 49. Associated British Foods Major Business
Table 50. Associated British Foods Pharmaceutical Excipients Product and Services
Table 51. Associated British Foods Pharmaceutical Excipients Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Associated British Foods Recent Developments/Updates
Table 53. Hunan ER-KANG Basic Information, Manufacturing Base and Competitors
Table 54. Hunan ER-KANG Major Business
Table 55. Hunan ER-KANG Pharmaceutical Excipients Product and Services
Table 56. Hunan ER-KANG Pharmaceutical Excipients Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Hunan ER-KANG Recent Developments/Updates
Table 58. Anhui Sunhere Basic Information, Manufacturing Base and Competitors
Table 59. Anhui Sunhere Major Business
Table 60. Anhui Sunhere Pharmaceutical Excipients Product and Services
Table 61. Anhui Sunhere Pharmaceutical Excipients Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Anhui Sunhere Recent Developments/Updates
Table 63. Tianjin Chase Sun Basic Information, Manufacturing Base and Competitors
Table 64. Tianjin Chase Sun Major Business
Table 65. Tianjin Chase Sun Pharmaceutical Excipients Product and Services
Table 66. Tianjin Chase Sun Pharmaceutical Excipients Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Tianjin Chase Sun Recent Developments/Updates
Table 68. Mitsubishi Basic Information, Manufacturing Base and Competitors
Table 69. Mitsubishi Major Business
Table 70. Mitsubishi Pharmaceutical Excipients Product and Services
Table 71. Mitsubishi Pharmaceutical Excipients Sales Quantity (K Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Mitsubishi Recent Developments/Updates
Table 73. Global Pharmaceutical Excipients Sales Quantity by Manufacturer (2018-2023) & (K Tons)
Table 74. Global Pharmaceutical Excipients Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Pharmaceutical Excipients Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 76. Market Position of Manufacturers in Pharmaceutical Excipients, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Pharmaceutical Excipients Production Site of Key Manufacturer
Table 78. Pharmaceutical Excipients Market: Company Product Type Footprint
Table 79. Pharmaceutical Excipients Market: Company Product Application Footprint
Table 80. Pharmaceutical Excipients New Market Entrants and Barriers to Market Entry
Table 81. Pharmaceutical Excipients Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Pharmaceutical Excipients Sales Quantity by Region (2018-2023) & (K Tons)
Table 83. Global Pharmaceutical Excipients Sales Quantity by Region (2024-2029) & (K Tons)
Table 84. Global Pharmaceutical Excipients Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Pharmaceutical Excipients Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Pharmaceutical Excipients Average Price by Region (2018-2023) & (US$/Ton)
Table 87. Global Pharmaceutical Excipients Average Price by Region (2024-2029) & (US$/Ton)
Table 88. Global Pharmaceutical Excipients Sales Quantity by Type (2018-2023) & (K Tons)
Table 89. Global Pharmaceutical Excipients Sales Quantity by Type (2024-2029) & (K Tons)
Table 90. Global Pharmaceutical Excipients Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Pharmaceutical Excipients Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Pharmaceutical Excipients Average Price by Type (2018-2023) & (US$/Ton)
Table 93. Global Pharmaceutical Excipients Average Price by Type (2024-2029) & (US$/Ton)
Table 94. Global Pharmaceutical Excipients Sales Quantity by Application (2018-2023) & (K Tons)
Table 95. Global Pharmaceutical Excipients Sales Quantity by Application (2024-2029) & (K Tons)
Table 96. Global Pharmaceutical Excipients Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Pharmaceutical Excipients Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Pharmaceutical Excipients Average Price by Application (2018-2023) & (US$/Ton)
Table 99. Global Pharmaceutical Excipients Average Price by Application (2024-2029) & (US$/Ton)
Table 100. North America Pharmaceutical Excipients Sales Quantity by Type (2018-2023) & (K Tons)
Table 101. North America Pharmaceutical Excipients Sales Quantity by Type (2024-2029) & (K Tons)
Table 102. North America Pharmaceutical Excipients Sales Quantity by Application (2018-2023) & (K Tons)
Table 103. North America Pharmaceutical Excipients Sales Quantity by Application (2024-2029) & (K Tons)
Table 104. North America Pharmaceutical Excipients Sales Quantity by Country (2018-2023) & (K Tons)
Table 105. North America Pharmaceutical Excipients Sales Quantity by Country (2024-2029) & (K Tons)
Table 106. North America Pharmaceutical Excipients Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Pharmaceutical Excipients Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Pharmaceutical Excipients Sales Quantity by Type (2018-2023) & (K Tons)
Table 109. Europe Pharmaceutical Excipients Sales Quantity by Type (2024-2029) & (K Tons)
Table 110. Europe Pharmaceutical Excipients Sales Quantity by Application (2018-2023) & (K Tons)
Table 111. Europe Pharmaceutical Excipients Sales Quantity by Application (2024-2029) & (K Tons)
Table 112. Europe Pharmaceutical Excipients Sales Quantity by Country (2018-2023) & (K Tons)
Table 113. Europe Pharmaceutical Excipients Sales Quantity by Country (2024-2029) & (K Tons)
Table 114. Europe Pharmaceutical Excipients Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Pharmaceutical Excipients Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Pharmaceutical Excipients Sales Quantity by Type (2018-2023) & (K Tons)
Table 117. Asia-Pacific Pharmaceutical Excipients Sales Quantity by Type (2024-2029) & (K Tons)
Table 118. Asia-Pacific Pharmaceutical Excipients Sales Quantity by Application (2018-2023) & (K Tons)
Table 119. Asia-Pacific Pharmaceutical Excipients Sales Quantity by Application (2024-2029) & (K Tons)
Table 120. Asia-Pacific Pharmaceutical Excipients Sales Quantity by Region (2018-2023) & (K Tons)
Table 121. Asia-Pacific Pharmaceutical Excipients Sales Quantity by Region (2024-2029) & (K Tons)
Table 122. Asia-Pacific Pharmaceutical Excipients Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Pharmaceutical Excipients Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Pharmaceutical Excipients Sales Quantity by Type (2018-2023) & (K Tons)
Table 125. South America Pharmaceutical Excipients Sales Quantity by Type (2024-2029) & (K Tons)
Table 126. South America Pharmaceutical Excipients Sales Quantity by Application (2018-2023) & (K Tons)
Table 127. South America Pharmaceutical Excipients Sales Quantity by Application (2024-2029) & (K Tons)
Table 128. South America Pharmaceutical Excipients Sales Quantity by Country (2018-2023) & (K Tons)
Table 129. South America Pharmaceutical Excipients Sales Quantity by Country (2024-2029) & (K Tons)
Table 130. South America Pharmaceutical Excipients Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Pharmaceutical Excipients Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Pharmaceutical Excipients Sales Quantity by Type (2018-2023) & (K Tons)
Table 133. Middle East & Africa Pharmaceutical Excipients Sales Quantity by Type (2024-2029) & (K Tons)
Table 134. Middle East & Africa Pharmaceutical Excipients Sales Quantity by Application (2018-2023) & (K Tons)
Table 135. Middle East & Africa Pharmaceutical Excipients Sales Quantity by Application (2024-2029) & (K Tons)
Table 136. Middle East & Africa Pharmaceutical Excipients Sales Quantity by Region (2018-2023) & (K Tons)
Table 137. Middle East & Africa Pharmaceutical Excipients Sales Quantity by Region (2024-2029) & (K Tons)
Table 138. Middle East & Africa Pharmaceutical Excipients Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Pharmaceutical Excipients Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Pharmaceutical Excipients Raw Material
Table 141. Key Manufacturers of Pharmaceutical Excipients Raw Materials
Table 142. Pharmaceutical Excipients Typical Distributors
Table 143. Pharmaceutical Excipients Typical Customers
List of Figures
Figure 1. Pharmaceutical Excipients Picture
Figure 2. Global Pharmaceutical Excipients Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pharmaceutical Excipients Consumption Value Market Share by Type in 2022
Figure 4. Triglycerides Examples
Figure 5. Mannitol Examples
Figure 6. Sorbitol Examples
Figure 7. Sucrose Examples
Figure 8. Dextrose Examples
Figure 9. Starch Examples
Figure 10. Others Examples
Figure 11. Global Pharmaceutical Excipients Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 12. Global Pharmaceutical Excipients Consumption Value Market Share by Application in 2022
Figure 13. Oral Formulations Examples
Figure 14. Topical Formulations Examples
Figure 15. Parenteral Formulations Examples
Figure 16. Other Examples
Figure 17. Global Pharmaceutical Excipients Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 18. Global Pharmaceutical Excipients Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 19. Global Pharmaceutical Excipients Sales Quantity (2018-2029) & (K Tons)
Figure 20. Global Pharmaceutical Excipients Average Price (2018-2029) & (US$/Ton)
Figure 21. Global Pharmaceutical Excipients Sales Quantity Market Share by Manufacturer in 2022
Figure 22. Global Pharmaceutical Excipients Consumption Value Market Share by Manufacturer in 2022
Figure 23. Producer Shipments of Pharmaceutical Excipients by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 24. Top 3 Pharmaceutical Excipients Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Top 6 Pharmaceutical Excipients Manufacturer (Consumption Value) Market Share in 2022
Figure 26. Global Pharmaceutical Excipients Sales Quantity Market Share by Region (2018-2029)
Figure 27. Global Pharmaceutical Excipients Consumption Value Market Share by Region (2018-2029)
Figure 28. North America Pharmaceutical Excipients Consumption Value (2018-2029) & (USD Million)
Figure 29. Europe Pharmaceutical Excipients Consumption Value (2018-2029) & (USD Million)
Figure 30. Asia-Pacific Pharmaceutical Excipients Consumption Value (2018-2029) & (USD Million)
Figure 31. South America Pharmaceutical Excipients Consumption Value (2018-2029) & (USD Million)
Figure 32. Middle East & Africa Pharmaceutical Excipients Consumption Value (2018-2029) & (USD Million)
Figure 33. Global Pharmaceutical Excipients Sales Quantity Market Share by Type (2018-2029)
Figure 34. Global Pharmaceutical Excipients Consumption Value Market Share by Type (2018-2029)
Figure 35. Global Pharmaceutical Excipients Average Price by Type (2018-2029) & (US$/Ton)
Figure 36. Global Pharmaceutical Excipients Sales Quantity Market Share by Application (2018-2029)
Figure 37. Global Pharmaceutical Excipients Consumption Value Market Share by Application (2018-2029)
Figure 38. Global Pharmaceutical Excipients Average Price by Application (2018-2029) & (US$/Ton)
Figure 39. North America Pharmaceutical Excipients Sales Quantity Market Share by Type (2018-2029)
Figure 40. North America Pharmaceutical Excipients Sales Quantity Market Share by Application (2018-2029)
Figure 41. North America Pharmaceutical Excipients Sales Quantity Market Share by Country (2018-2029)
Figure 42. North America Pharmaceutical Excipients Consumption Value Market Share by Country (2018-2029)
Figure 43. United States Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Canada Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Mexico Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Europe Pharmaceutical Excipients Sales Quantity Market Share by Type (2018-2029)
Figure 47. Europe Pharmaceutical Excipients Sales Quantity Market Share by Application (2018-2029)
Figure 48. Europe Pharmaceutical Excipients Sales Quantity Market Share by Country (2018-2029)
Figure 49. Europe Pharmaceutical Excipients Consumption Value Market Share by Country (2018-2029)
Figure 50. Germany Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. France Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. United Kingdom Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Russia Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Italy Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Asia-Pacific Pharmaceutical Excipients Sales Quantity Market Share by Type (2018-2029)
Figure 56. Asia-Pacific Pharmaceutical Excipients Sales Quantity Market Share by Application (2018-2029)
Figure 57. Asia-Pacific Pharmaceutical Excipients Sales Quantity Market Share by Region (2018-2029)
Figure 58. Asia-Pacific Pharmaceutical Excipients Consumption Value Market Share by Region (2018-2029)
Figure 59. China Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Japan Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Korea Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. India Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Southeast Asia Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Australia Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. South America Pharmaceutical Excipients Sales Quantity Market Share by Type (2018-2029)
Figure 66. South America Pharmaceutical Excipients Sales Quantity Market Share by Application (2018-2029)
Figure 67. South America Pharmaceutical Excipients Sales Quantity Market Share by Country (2018-2029)
Figure 68. South America Pharmaceutical Excipients Consumption Value Market Share by Country (2018-2029)
Figure 69. Brazil Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Argentina Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Middle East & Africa Pharmaceutical Excipients Sales Quantity Market Share by Type (2018-2029)
Figure 72. Middle East & Africa Pharmaceutical Excipients Sales Quantity Market Share by Application (2018-2029)
Figure 73. Middle East & Africa Pharmaceutical Excipients Sales Quantity Market Share by Region (2018-2029)
Figure 74. Middle East & Africa Pharmaceutical Excipients Consumption Value Market Share by Region (2018-2029)
Figure 75. Turkey Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Egypt Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Saudi Arabia Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. South Africa Pharmaceutical Excipients Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 79. Pharmaceutical Excipients Market Drivers
Figure 80. Pharmaceutical Excipients Market Restraints
Figure 81. Pharmaceutical Excipients Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Pharmaceutical Excipients in 2022
Figure 84. Manufacturing Process Analysis of Pharmaceutical Excipients
Figure 85. Pharmaceutical Excipients Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
